Home > News > Starpharma: Human Trials of Anti-HIV Product
July 31st, 2003
Starpharma: Human Trials of Anti-HIV Product
Abstract:
Melbourne biotech company Starpharma Pooled Development Ltd has received FDA clearance to proceed with human clinical trials of its new dendrimer nano-drug VivaGel. The gel will be used as a preventative against the transmission of HIV during sexual intercourse. It has been highly successful in preventing infection in monkey trials using a humanised strain of simian immunodeficiency virus.
Source:
Starpharma
Bookmark:
| Related News Press |
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||